Regeneron Pharmaceuticals Inc.

VelociTUnique Mouse Technology

SHARE

elociT is our unique mouse technology for producing fully human therapeutic T-cell receptors (TCR) against tumor and viral antigens. Regeneron uses this technology as part of its efforts to discover and develop novel immuno-oncology therapeutic candidates, including combination approaches and to assist our collaborators in producing fully human therapeutic TCRs.